Friday, 25 September 2026European Markets

ALUMEXX N.V. Stock Impressive Rise On Tuesday, Outperforms Market

Loading stream...

(VIANEWS) - The Market ended the session with ALUMEXX N.V. (ALX.AS) jumping 18.97% to €1.38 on Tuesday, after two successive sessions in a row of gains. AEX-Index rose 0.82% to €831.09, after three sequential sessions in a row of gains, on what was a somewhat up trend exchanging session today.

ALUMEXX N.V.'s last close was €1.16, 12.12% under its 52-week high of €1.32.

About ALUMEXX N.V.

Alumexx N.V. manufactures and sells scaffoldings, stairs, ladders, accessories, and tools for indoor or outdoor use in the Netherlands and internationally. The company was formerly known as Phelix N.V. and changed its name to Alumexx N.V. in January 2018. Alumexx N.V. was founded in 1991 and is based in Etten-Leur, the Netherlands.

Earnings Per Share

As for profitability, ALUMEXX N.V. has a trailing twelve months EPS of €0.12.

PE Ratio

ALUMEXX N.V. has a trailing twelve months price to earnings ratio of 11.5. Meaning, the purchaser of the share is investing €11.5 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 42.26%.

Moving Average

ALUMEXX N.V.'s value is way higher than its 50-day moving average of €0.92 and way above its 200-day moving average of €0.73.

Yearly Top and Bottom Value

ALUMEXX N.V.'s stock is valued at €1.38 at 21:30 EST, higher than its 52-week high of €1.32.

Revenue Growth

Year-on-year quarterly revenue growth grew by 303.1%, now sitting on 19.57M for the twelve trailing months.

More news about ALUMEXX N.V. (ALX.AS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI Agents Scale Up Through Partnerships and Funding, But Data Readiness Lags Ambition
A wave of vertical AI-agent startups (Swarm, Veridox, Avallon AI, DA2, F2, Earthian, Meanwhile, Covecta, Penguin AI, Maisa AI) is being funded and profiled just as major infrastructure players — Microsoft/Mistral, Siemens/NVIDIA, and Manulife/Microsoft — cement enterprise AI governance and compute partnerships. Yet a Google Cloud report shows AI agents still lack access to the majority of company data (only 45% on average), and insider selling at incumbent C3.ai signals investor caution even as adoption intent (100% planned agentic AI use within two years) races ahead of actual data infrastructure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,984
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,984 facts checked against source5,306 source documents archived
Query this data → isubstrate.com